PRVANasdaqServices-Health ServicesFiscal year ends December 31
Privia Health Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$22.44−0.08 (-0.36%)
Close on Oct 19, 2026
- Market cap
- $2.96B
- P/E (TTM)
- 106.9
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
96.7%
124M of 128M shares
Institutional holders
301
46 new, 34 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 40 sales
Net sold $22.24M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rubicon Founders LLC | 6,472,513 | 5.07% | 13D (active) | Sep 1, 2026 |
| FMR LLC | 6,385,121 | 5.00% | 13G (passive) amendment | Sep 30, 2026 |
| Vanguard Portfolio Management | 6,382,685 | 5.16% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 17,929,937 | 14.20% | 13G (passive) amendment | Jun 30, 2026 |
| Durable Capital Partners LP | 11,109,588 | 9.30% | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PRVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 21,402,417 | 16.76% | $550.68M | +2,344,507 | 0.01% |
| FMR LLC | 12,848,437 | 10.06% | $330.59M | −197,105 | 0.01% |
| Durable Capital Partners LP | 11,635,948 | 9.11% | $299.39M | −451,895 | 2.91% |
| Vanguard Portfolio Management LLC | 6,572,384 | 5.15% | $169.11M | +290,842 | 0.01% |
| Rubicon Founders LLC | 5,971,079 | 4.67% | $153.64M | +22,415 | 78.21% |
| Vanguard Capital Management LLC | 5,156,720 | 4.04% | $132.68M | +147,897 | 0.00% |
| State Street Corp | 4,905,789 | 3.84% | $126.23M | +415,889 | 0.00% |
| Van Berkom & Associates Inc. | 3,711,623 | 2.91% | $95.50K | −4,394,463 | 3.08% |
| Geode Capital Management, LLC | 3,130,473 | 2.45% | $80.56M | +234,939 | 0.00% |
| Riverbridge Partners LLC | 2,998,597 | 2.35% | $77.15M | −919,351 | 2.15% |
| Bank of New York Mellon Corp | 2,892,536 | 2.26% | $74.42M | −50,957 | 0.01% |
| Principal Financial Group Inc | 2,587,878 | 2.03% | $66.59M | −135,195 | 0.03% |
| Dimensional Fund Advisors LP | 2,551,861 | 2.00% | $65.66M | +145,144 | 0.01% |
| Wellington Management Group Llp | 2,130,289 | 1.67% | $54.81M | +1,906,187 | 0.01% |
| UBS Asset Management Americas Inc | 1,948,021 | 1.53% | $50.12M | −103,638 | 0.01% |
| BlackBarn Capital Partners LP | 1,585,000 | 1.24% | $40.78M | – | 3.44% |
| Nuveen, LLC | 1,465,145 | 1.15% | $37.70M | +517,009 | 0.01% |
| Bank Of America Corp /De/ | 1,432,117 | 1.12% | $36.85M | +175,939 | 0.00% |
| Charles Schwab Investment Management Inc | 1,374,828 | 1.08% | $35.37M | +55,722 | 0.00% |
| Goldman Sachs Group Inc | 1,302,019 | 1.02% | $33.50M | −37,931 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 301 | 124M | 96.7% | 46 / 114 | 102 / 34 | 10M | 12M |
| Q1 2026 | 293 | 125M | 97.8% | 52 / 102 | 98 / 31 | 23M | 7M |
| Q4 2025 | 276 | 121M | 94.6% | 49 / 112 | 76 / 27 | 6M | 4M |
| Q3 2025 | 259 | 120M | 93.8% | 31 / 104 | 87 / 50 | 10M | 8M |
| Q2 2025 | 281 | 118M | 92.3% | 53 / 109 | 88 / 19 | 8M | 11M |
| Q1 2025 | 249 | 121M | 94.6% | 37 / 88 | 87 / 17 | 11M | 8M |
| Q4 2024 | 231 | 120M | 94.1% | 27 / 102 | 64 / 30 | 6M | 6M |
| Q3 2024 | 234 | 120M | 93.9% | 32 / 78 | 89 / 21 | 26M | 7M |
| Q2 2024 | 225 | 118M | 92.5% | 30 / 70 | 93 / 36 | 8M | 10M |
| Q1 2024 | 233 | 121M | 94.8% | 37 / 96 | 69 / 28 | 10M | 7M |
| Q4 2023 | 226 | 118M | 92.7% | 31 / 97 | 71 / 19 | 13M | 6M |
| Q3 2023 | 218 | 111M | 86.9% | 28 / 90 | 71 / 42 | 8M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PRVA | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7,137,000 | 5.59% | $183.64M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,589,974 | 2.81% | $92.37M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,146,350 | 2.46% | $80.96M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,599,416 | 2.04% | $66.88M | 0.04% | Jun 30, 2026 |
| Select Health Care Portfolio | 2,500,000 | 1.96% | $53.78M | 0.93% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,501,521 | 1.18% | $38.63M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,359,812 | 1.06% | $34.99M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,321,438 | 1.03% | $31.28M | 0.09% | Jul 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,285,000 | 1.01% | $27.64M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Growth Fund | 1,283,039 | 1.00% | $30.37M | 0.35% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,115,917 | 0.87% | $28.71M | 0.19% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 1,085,362 | 0.85% | $27.93M | 0.17% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 1,065,858 | 0.83% | $27.42M | 0.33% | Jun 30, 2026 |
| Franklin Small Cap Growth Fund | 1,039,286 | 0.81% | $24.60M | 1.00% | Jul 31, 2026 |
| Fidelity Advisor Health Care Fund | 896,700 | 0.70% | $21.22M | 0.68% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Parth Mehrotra | Chief Executive Officer, Director | 437,174 | 0.34% | May 13, 2026 |
| David Mountcastle | EVP & Chief Financial Officer | 173,548 | 0.14% | Jul 13, 2026 |
| Edward C. Fargis | EVP & General Counsel | 111,979 | 0.09% | Mar 12, 2026 |
| Opella Finley Ernest | Director | 6,350 | 0.00% | Sep 3, 2026 |
| Matthew Shawn Morris | Director | 154,858 | 0.12% | Jul 7, 2026 |
| Lance Berberian | Director | 16,131 | 0.01% | May 22, 2026 |
| Pamela O. Kimmet | Director | 34,172 | 0.03% | May 22, 2026 |
| Francis S. Soistman Jr | Director | 8,463 | 0.01% | May 22, 2026 |
| Nancy G. Cocozza | Director | 42,814 | 0.03% | May 22, 2026 |
| Thomas A. McCarthy | Director | 69,470 | 0.05% | May 22, 2026 |
| David P. King | Director | 50,775 | 0.04% | May 22, 2026 |
| Jaewon Ryu | Director | 47,110 | 0.04% | May 22, 2026 |
| David S. Wichmann | Director | 1,341,049 | 1.05% | May 23, 2025 |
| Patricia Anne Maryland | Director | 42,312 | 0.03% | May 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Opella Finley Ernest Director | Sep 1, 2026 | Award | +6,350 | – | – | 6,350 |
| David Mountcastle EVP & Chief Financial Officer | Jul 9, 2026 | Sale(10b5-1 plan) | −21,275 | $27.67 | $588.68K | 164,853 |
| David Mountcastle EVP & Chief Financial Officer | Jul 7, 2026 | Sale(10b5-1 plan) | −600 | $27.57 | $16.54K | 186,128 |
| Matthew Shawn Morris Director | Jul 6, 2026 | Option exercise | +53,722 | $2.00 | $107.44K | 130,373 |
| Matthew Shawn Morris Director | Jul 6, 2026 | Sale(10b5-1 plan) | −53,722 | $27.24 | $1.46M | 68,188 |
| David Mountcastle EVP & Chief Financial Officer | Jul 2, 2026 | Sale(10b5-1 plan) | −24,734 | $27.50 | $680.19K | 186,728 |
| Matthew Shawn Morris Director | Jul 2, 2026 | Sale(10b5-1 plan) | −59,037 | $27.33 | $1.61M | 76,651 |
| Matthew Shawn Morris Director | Jul 2, 2026 | Option exercise | +59,037 | $2.00 | $118.07K | 135,688 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Option exercise | +82,675 | $2.00 | $165.35K | 159,326 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Sale(10b5-1 plan) | −45,634 | $26.52 | $1.21M | 113,692 |
| Matthew Shawn Morris Director | Jul 1, 2026 | Sale(10b5-1 plan) | −37,041 | $26.93 | $997.51K | 76,651 |
| Matthew Shawn Morris Director | Jun 30, 2026 | Option exercise | +52,823 | $2.00 | $105.65K | 129,474 |
| Matthew Shawn Morris Director | Jun 30, 2026 | Sale(10b5-1 plan) | −52,823 | $25.72 | $1.36M | 76,651 |
| Matthew Shawn Morris Director | Jun 29, 2026 | Option exercise | +63,212 | $2.00 | $126.42K | 139,863 |
| Matthew Shawn Morris Director | Jun 29, 2026 | Sale(10b5-1 plan) | −63,212 | $25.33 | $1.60M | 76,651 |
| David Mountcastle EVP & Chief Financial Officer | Jun 26, 2026 | Option exercise | +17,196 | $2.00 | $34.39K | 228,658 |
| David Mountcastle EVP & Chief Financial Officer | Jun 26, 2026 | Sale(10b5-1 plan) | −17,196 | $25.18 | $433.00K | 211,462 |
| Matthew Shawn Morris Director | Jun 26, 2026 | Sale(10b5-1 plan) | −88,110 | $25.33 | $2.23M | 76,651 |
| Matthew Shawn Morris Director | Jun 26, 2026 | Option exercise | +88,110 | $2.00 | $176.22K | 164,761 |
| Nancy G. Cocozza Director | May 20, 2026 | Award | +8,463 | – | – | 42,814 |
| Lance Berberian Director | May 20, 2026 | Award | +8,463 | – | – | 16,131 |
| David P. King Director | May 20, 2026 | Award | +8,463 | – | – | 50,775 |
| Thomas A. McCarthy Director | May 20, 2026 | Award | +8,463 | – | – | 27,983 |
| Jaewon Ryu Director | May 20, 2026 | Award | +8,463 | – | – | 47,110 |
| Matthew Shawn Morris Director | May 20, 2026 | Award | +8,463 | – | – | 76,651 |
| Francis S. Soistman Jr Director | May 20, 2026 | Award | +8,463 | – | – | 8,463 |
| Pamela O. Kimmet Director | May 20, 2026 | Award | +8,463 | – | – | 34,172 |
| Parth Mehrotra Chief Executive Officer, Director | May 12, 2026 | Sale(10b5-1 plan) | −15,647 | $22.64 | $354.25K | 434,357 |
| David Mountcastle EVP & Chief Financial Officer | May 11, 2026 | Sale | −3,385 | $22.60 | $76.50K | 211,462 |
| Parth Mehrotra Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −105,439 | $22.55 | $2.38M | 450,004 |
| Matthew Shawn Morris Director | May 4, 2026 | Sale(10b5-1 plan) | −1,017 | $24.96 | $25.38K | 68,188 |
| Matthew Shawn Morris Director | May 4, 2026 | Option exercise | +1,017 | $2.00 | $2.03K | 69,205 |
| David Mountcastle EVP & Chief Financial Officer | May 4, 2026 | Sale(10b5-1 plan) | −1,206 | $25.00 | $30.15K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | May 4, 2026 | Option exercise | +1,206 | $2.00 | $2.41K | 216,053 |
| Matthew Shawn Morris Director | May 1, 2026 | Option exercise | +17,096 | $2.00 | $34.19K | 85,284 |
| Matthew Shawn Morris Director | May 1, 2026 | Sale(10b5-1 plan) | −17,096 | $24.99 | $427.23K | 68,188 |
| David Mountcastle EVP & Chief Financial Officer | May 1, 2026 | Option exercise | +7,179 | $2.00 | $14.36K | 222,026 |
| David Mountcastle EVP & Chief Financial Officer | May 1, 2026 | Sale(10b5-1 plan) | −7,179 | $25.03 | $179.69K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | Apr 2, 2026 | Sale | −5,566 | $20.85 | $116.05K | 214,847 |
| David Mountcastle EVP & Chief Financial Officer | Mar 16, 2026 | Sale | −6,391 | $22.11 | $141.31K | 220,413 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 16, 2026 | Sale | −26,509 | $22.11 | $586.11K | 555,443 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 13, 2026 | Sale | −27,229 | $21.52 | $585.97K | 581,952 |
| David Mountcastle EVP & Chief Financial Officer | Mar 13, 2026 | Sale | −6,565 | $21.52 | $141.28K | 226,804 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 12, 2026 | Sale | −26,763 | $21.90 | $586.11K | 609,181 |
| David Mountcastle EVP & Chief Financial Officer | Mar 12, 2026 | Sale | −6,453 | $21.90 | $141.32K | 233,369 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 11, 2026 | Award | +171,904 | – | – | 635,944 |
| David Mountcastle EVP & Chief Financial Officer | Mar 11, 2026 | Award | +42,584 | – | – | 239,822 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 10, 2026 | Sale(10b5-1 plan) | −21,097 | $22.71 | $479.11K | 322,698 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 10, 2026 | Award | +141,342 | – | – | 464,040 |
| David Mountcastle EVP & Chief Financial Officer | Mar 10, 2026 | Award | +35,335 | – | – | 197,238 |
| Edward C. Fargis EVP & General Counsel | Mar 10, 2026 | Award | +28,268 | – | – | 111,979 |
| David Mountcastle EVP & Chief Financial Officer | Mar 9, 2026 | Sale | −5,829 | $22.84 | $133.13K | 161,903 |
| Edward C. Fargis EVP & General Counsel | Mar 9, 2026 | Sale | −4,949 | $22.84 | $113.04K | 83,711 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −1,219 | $23.37 | $28.49K | 362,660 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −18,865 | $22.84 | $430.88K | 343,795 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −21,915 | $22.84 | $500.54K | 363,879 |
| David Mountcastle EVP & Chief Financial Officer | Mar 6, 2026 | Sale | −5,177 | $23.15 | $119.85K | 167,732 |
| Edward C. Fargis EVP & General Counsel | Mar 6, 2026 | Sale | −4,394 | $23.15 | $101.72K | 88,660 |
| Parth Mehrotra Chief Executive Officer, Director | Mar 6, 2026 | Sale(10b5-1 plan) | −21,440 | $23.15 | $496.34K | 385,794 |
| Matthew Shawn Morris Director | Feb 27, 2026 | Option exercise | +16,550 | $2.00 | $33.10K | 84,738 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David Mountcastle Officer | Jul 9, 2026 | 21,275 | $588.60K | Jul 9, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jul 7, 2026 | 600 | $16.54K | Jul 7, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jul 2, 2026 | 24,734 | $680.19K | Jul 2, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Jun 26, 2026 | 17,196 | $433.04K | Jun 26, 2026 | Stock Option Exercise |
| Parth Mehrotra Officer, Director | May 12, 2026 | 15,647 | $354.25K | May 12, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | May 11, 2026 | 14,036 | $317.26K | May 11, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | May 11, 2026 | 3,385 | $76.51K | May 11, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | May 11, 2026 | 91,403 | $2.06M | May 11, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | May 4, 2026 | 1,206 | $30.15K | May 4, 2026 | Option Granted - 08/28/2018 |
| David Mountcastle Officer | May 1, 2026 | 7,179 | $179.68K | May 1, 2026 | Options Granted - 08/28/2018 |
| Shawn Morris Matthew Director | May 1, 2026 | 1,628,683 | $40.47M | May 1, 2026 | Acquired as compensation -- Restricted Stock Units |
| David Mountcastle Officer | Apr 2, 2026 | 5,566 | $116.06K | Apr 2, 2026 | Restricted Stock Vesting |
| David Mountcastle Officer | Mar 16, 2026 | 6,391 | $141.30K | Mar 16, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | Mar 16, 2026 | 26,509 | $586.11K | Mar 16, 2026 | Restricted Stock Vesting |
| Parth Mehrotra Officer, Director | Mar 13, 2026 | 27,229 | $586.12K | Mar 13, 2026 | Restricted Stock Vesting |